Health-related quality of life in chronic hepatitis C: Impact of disease and treatment response

Hepatology

Volumn 30, Issue 2, 1999, Pages 550-555

  Ware Jr , John E ^a,b,c,d   Bayliss, Martha S ^a,b,d   Mannocchia, Michael ^e   Davis, Gary L ^f  

^a TUFTS MEDICAL CENTER   (United States)

^b QualityMetric Incorporated   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e Picker Institute   (United States)

^f UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REBETRON; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

FEMALE; HEALTH STATUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; MALE; QUALITY OF LIFE; RIBAVIRIN;

EID: 0032769168     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300203     Document Type: Article

References (17)

1. McQuillan GM, Alter MJ, Moyer LA, Lambert SB, Margolis HS. A population-based serologic study of hepatitis C virus infection in the United States. In: Rizetto M, Purcell RH, Gerin JL, Verne G, eds. Viral Hepatitis and Liver Disease. Turin: Edizioni Minerva Medica, 1997;267-270.
2. Carithers RL, Sugano D, Bayliss M. Health assessment for chronic HCV: Results of HQL. Dig Dis Sci 1996;41(Suppl 12):75S-80S.
3. Davis GL, Balert LA, Schiff ER, Lindsay K, Bodenheimer HC Jr, Perillo RP, Carey W, et al. Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile. Clin Ther 1994;16:334-343.
4. Bayliss MS, Gandek B, Bungay KM, Sugano D, Hsu MA, Ware JE Jr. A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C. Qual Life Res 1998;7:39-55.
5. Bonkovsky HL, Woolley JM, and the Consensus Interferon Study Group. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. HEPATOLOGY 1999;29:264-270.
6. Wachtel T, Piette J, Mor V, Stein M, Fleishman J, Carpenter C. HQL in persons with human immunodeficiency virus infection: measurement by the Medical Outcomes Study instrument. Ann Intern Med 1992;116:129-137.
7. Davis GL, Esteban-Mur R, Rustgi V, Hops J, Gordin SC, Trepo C, Shiffman ML, et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse in chronic hepatitis C. N Engl J Med 1998;339:1493-1499.
8. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. HEPATOLOGY 1981;1:431-435.
9. McHorney CA, Ware JE, Lu JFR, Sherbourne CD. The Medical Outcomes Study (MOS) 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions and reliability across diverse patients groups. Med Care 1994;32:40-66.
10. McHorney CA, Ware JE, Raczek AE. The Medical Outcomes Study (MOS) 36-item short-form health status survey (SF-36): 11. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-263.
11. Brazier JE, Harper R, Jones NMB, O'Cathain A, Thomas KJ, Usherwood T, Westlake L. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992;305:160-164.
12. Katz JN, Larson MG, Phillips CB, Fossel AH, Liang MH. Comparative measurement sensitivity of short and longer health status instruments. Med Care 1992;30:917-925.
13. Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT. The SF-36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ 1993;306:1440-1444.
14. Phillips RC, Lansky DJ. Outcomes management in heart valve replacement surgery: early experience. J Heart Valve Dis 1992;1:42-50.
15. Kurtin PS, Davies AR, Meyer KB, DeGiacomo JM, Kantz ME. Patient-based health status measures in outpatient dialysis: early experiences in developing an outcomes assessment program. Med Care 1992;30:MS136-MS149.
16. Gandek B, Ware JE. SF-36 Health Survey Manual and Interpretation Guide. Boston: New England Medical Center, The Health Institute, 1993.
17. Ware JE, Keller SD, Gandek B, Brazier JE, Sullivan M. Evaluating translations of health status questionnaires. Methods from the IQOLA project. Int J Technol Assess Health Care 1995;11:525-551.